Salem resident Joni Johnston testified to the Missouri General Assembly’s House Emerging Issues Committee Jan. 20. Johnston spoke in consideration of House Bill 1366, which would mandate more communication between patients, pharmacists and physicians when medication is being substituted with a biosimilar alternative.